Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Open-label Study Evaluating the Safety and Efficacy of AGE Serum in Non-menopausal Patients on Glucagon-like Peptide-1 Agonists
Authors not listed
Goldman, Butterwick, Fitzpatrick and Groff · 2025
Abstract
The primary objective is to evaluate the safety and efficacy of a topical serum (AGE serum) in improving visible signs of aging (e.g., fine lines, wrinkles, sagging, texture, radiance) on the full face and neck.The study will be conducted in non-menopausal female and male subjects who are on glucagon-like peptide-1 (GLP-1) agonist therapy for weight loss.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2025). Open-label Study Evaluating the Safety and Efficacy of AGE Serum in Non-menopausal Patients on Glucagon-like Peptide-1 Agonists. <em>Goldman, Butterwick, Fitzpatrick and Groff</em>. https://clinicaltrials.gov/study/NCT07216352
Vancouver
Anonymous. Open-label Study Evaluating the Safety and Efficacy of AGE Serum in Non-menopausal Patients on Glucagon-like Peptide-1 Agonists. Goldman, Butterwick, Fitzpatrick and Groff. 2025.
BibTeX
@misc{anon2025Openla,
title = {Open-label Study Evaluating the Safety and Efficacy of AGE Serum in Non-menopausal Patients on Glucagon-like Peptide-1 Agonists},
author = {Anonymous},
journal = {Goldman, Butterwick, Fitzpatrick and Groff},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.